Philips' medical imaging R&D division, developing AI-powered X-ray, MRI, and interventional systems through 32 H2020 projects across Europe.
Philips Medical Systems Nederland is the R&D and innovation arm of Philips Healthcare, developing advanced medical imaging and diagnostic systems — X-ray, MRI, ultrasound, and interventional guidance platforms. They build the hardware and software that hospitals use for diagnosis and image-guided treatment, from smart catheters in the cath lab to AI-powered image analysis. Their H2020 work focuses on pushing imaging technology forward: better detectors (perovskite X-ray sensors), smarter image processing (deep learning, neuromorphic computing), and miniaturized medical devices (micro-fabricated implants and catheters).
Core thread across NEXIS (next-gen X-ray), PEROXIS (perovskite X-ray detectors), LORIX (organic X-ray imagers), ASTONISH (smart optical imaging), NICI (MRI chemistry imaging), and INTUI-VIEW (ultrasound-guided interventions).
DeepHealth (deep learning for biomedical apps), HosmartAI (hospital AI), FITOPTIVIS (edge image processing), TEMPO (neuromorphic computing), INSPiRE-MED (ML for MR spectroscopy), and ANDANTE (AI at the edge).
POSITION-II (smart catheters with IVUS/FFR/ICE), INTUI-VIEW (needle tracking), InForMed and Moore4Medical (micro-fabricated medical devices), and MUSICARE (transcatheter procedures).
MANGO (manycore HPC architectures), oCPS (cyber-physical system optimization), SUPERCLOUD (cloud infrastructure), Arrowhead Tools (digitalization engineering), and TEMPO (neuromorphic ASIC design).
MANTIS (proactive collaborative maintenance), I-MECH (smart mechatronic systems), and ENABLE-S3 (validation of automated systems).
FORCE (imaging cancer mechanics via MR-elastography), RESILIENCE (cardiotoxicity from cancer treatment), and NICI (gastrointestinal cancer imaging with 3D organoids).
In the early period (2015–2018), Philips focused on foundational imaging hardware and computing infrastructure — organic X-ray sensors (LORIX), HPC architectures (MANGO), cloud security (SUPERCLOUD), and tissue modeling for interventional procedures (MUSICARE). From 2019 onward, the emphasis shifted decisively toward AI-powered imaging and edge computing: deep learning for medical images (DeepHealth), neuromorphic chips (TEMPO), hospital-wide AI deployment (HosmartAI), and next-generation detector materials like perovskites (PEROXIS). There is also a growing thread in cardio-oncology (RESILIENCE) and personalized metabolic imaging (NICI), signaling expansion from pure imaging hardware into clinical decision support.
Philips is moving from building imaging hardware to embedding AI directly into clinical workflows — future partners should bring machine learning, edge computing, or clinical validation expertise.
Philips Medical Systems overwhelmingly participates as a consortium partner (26 of 32 projects) rather than leading, which is typical for large industrial companies that contribute specific technology components to broader research efforts. They coordinated 5 projects, all in their core imaging domain (INTUI-VIEW, ASTONISH, NEXIS, FITOPTIVIS), where they had clear technology ownership. With 593 unique partners across 29 countries, they operate as a major network hub — but their role is that of an industrial end-user and technology integrator, bringing real products and clinical requirements into research consortia.
Extremely broad network of 593 unique consortium partners spanning 29 countries, reflecting Philips' position as a major European industrial player in health technology. The network is pan-European with no obvious geographic concentration beyond the Netherlands.
Philips Medical Systems is one of the few organizations in H2020 that sits at the exact intersection of medical device manufacturing, clinical imaging, and AI — they don't just research these topics, they build and sell the actual hospital equipment. This makes them an exceptionally valuable consortium partner: they bring real-world product requirements, clinical validation pathways, and a route to market that most research organizations cannot offer. For any project aiming to move imaging or diagnostic AI from the lab to the hospital, Philips is one of the strongest industrial anchors in Europe.
